FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Marianne Ellen Pavel
List of publications:
BibTeX-Download
Medizinische Fakultät
Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology
Professur für Endokrinologie
Publications
(150)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Efficacy and safety of high-dose lanreotide autogel in patients with progressive pancreatic or midgut neuroendocrine tumours: CLARINET FORTE phase 2 study results (2021)
Pavel ME, Ćwikła JB, Lombard-Bohas C, Borbath I, Shah T, Pape UF, Capdevila J, et al.
Journal article
Weight Maintenance up to 48 Weeks in Patients With Carcinoid Syndrome Treated With Telotristat Ethyl: Pooled Data From the Open-Label Extensions of the Phase III Clinical Trials TELESTAR and TELECAST (2021)
Srirajaskanthan R, Pavel ME, Kulke M, Clement D, Houchard A, Keeber L, Weickert MO
Journal article
Treatment strategy by radioiodine refractory differentiated thyroid cancer (2021)
Mantsopoulos K, Müller SK, Pavel ME, Kuwert T, Meidenbauer N, Fietkau R, Sievert M, Iro H
Journal article
The Phase 3 NETTER-1 Study of [Lu-177]Lu-DOTA-TATE in Patients with Midgut Neuroendocrine Tumours: Final Overall Survival and Long-Term Renal Safety (2021)
Kunz P, Caplin ME, Ruszniewski PB, Bodei L, Hendifar A, Mittra E, Wolin EM, et al.
Conference contribution
Survey of Challenges in Access to Diagnostics and Treatment for Neuroendocrine Tumor (NET) Patients (SCAN): PRRT in the Treatment of Neuroendocrine Tumor (NET) Patients (2021)
Dureja S, Kolarova T, Mcdonnell M, Van Genechten D, Bouvier C, Gellerman E, O'Toole D, et al.
Conference contribution
Tumor Growth Rate to Predict the Outcome of Patients with Neuroendocrine Tumors: Performance and Sources of Variability (2021)
Dromain C, Sundin A, Najran P, Vidal Trueba H, Dioguardi Burgio M, Crona J, Opalinska M, et al.
Journal article
Targeted inhibition of the WEE1 kinase as a novel therapeutic strategy in neuroendocrine neoplasms (2021)
Weindl L, Atreya I, Dietrich P, Neubeck S, Neurath M, Pavel ME
Journal article
Immune-checkpoint inhibitor-associated diabetes compared to other diabetes types - A prospective, matched control study (2021)
Tittel SR, Laubner K, Schmid SM, Kress S, Merger S, Karges W, Wosch FJ, et al.
Journal article
Target heterogeneity in oncology: The best predictor for differential response to radioligand therapy in neuroendocrine tumors and prostate cancer (2021)
Puranik AD, Dromain C, Fleshner N, Sathekge M, Pavel ME, Eberhardt N, Zengerling F, et al.
Journal article, Review article
Multicenter, Observational Study of Lanreotide Autogel for the Treatment of Patients with Neuroendocrine Tumors in Routine Clinical Practice in Germany and Austria (2021)
Rinke A, Maintz C, Muller L, Weber MM, Lahner H, Pavel ME, Saeger W, et al.
Journal article
‹
1
...
3
4
5
6
7
...
15
›